Abeona Therapeutics Inc
NASDAQ:ABEO
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
Abeona Therapeutics Inc
NASDAQ:ABEO
|
US |
|
C
|
CCL Industries Inc
OTC:CCDBF
|
CA |
|
A
|
Abbott Laboratories
SIX:ABT
|
US |
|
A
|
Accenture PLC
F:CSA
|
IE |
|
U
|
Under Armour Inc
F:U9RA
|
US |
|
B
|
Bank of China Ltd
DUS:W8V
|
CN |
Wall St Price Targets
ABEO Price Targets Summary
Abeona Therapeutics Inc
According to Wall Street analysts, the average 1-year price target for ABEO is 20.11 USD with a low forecast of 14.14 USD and a high forecast of 29.4 USD.
Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What you see on other sites is mostly sourced from sell-side analysts.
What is ABEO's stock price target?
Price Target
20.11
USD
According to Wall Street analysts, the average 1-year price target for ABEO is 20.11 USD with a low forecast of 14.14 USD and a high forecast of 29.4 USD.
What is the Revenue forecast for Abeona Therapeutics Inc?
Projected CAGR
233%
Over the last 14 years, the compound annual growth rate for Revenue has been 9%. The projected CAGR for the next 3 years is 233%.
What is the Gross Profit forecast for Abeona Therapeutics Inc?
Projected CAGR
280%
Over the last 14 years, the compound annual growth rate for Gross Profit has been 7%. The projected CAGR for the next 3 years is 280%.
What is the Pre-Tax Income forecast for Abeona Therapeutics Inc?
Projected CAGR
-22%
The compound annual growth rate for Pre-Tax Income over the next 3 years is -22%.
What is the Net Income forecast for Abeona Therapeutics Inc?
Projected CAGR
-20%
The compound annual growth rate for Net Income over the next 3 years is -20%.
